by Alex Kadhim
Researchers from the European Society for Blood and Marrow Transplantation (EBMT) have found that using posttransplant cyclophosphamide (ptCy) for graft-versus-host disease (GVHD) prophylaxis in...
by Alex Kadhim
Researchers at Roswell Park Comprehensive Cancer Center and the University of Minnesota have found that targeting the pentose phosphate pathway (PPP) in donor T cells can significantly reduce the...
by Journal of Clinical Investigation
Scientists developed a conditioning protocol that, followed by allogeneic bone marrow transplantation and islet transplantation, produces a favorable mix of host and donor hematopoietic stem cells...
by Bone Marrow Transplantation
Donor traits and graft sources have a role in how outcomes play out after haploidentical hematopoietic cell transplantation (HCT) for acute lymphoblastic leukemia (ALL), report members of a...
by Clinical & Translational Immunology
Preclinical evidence warrants further testing of P2X7 blockades as a preventative therapy against graft-versus-host disease (GVHD), a complication of allogeneic hematopoietic stem cell...
by Alex Kadhim
Researchers at the Weizmann Institute of Science, in collaboration with the Socié lab, have generated a high-resolution spatial atlas of the human gastrointestinal tract in acute graft-versus-host...